Atlas Trials

Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology

Clinical trial NCT06865898 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06865898
Sponsor
Qilu Hospital of Shandong University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
HBV Related Acute-on-chronic Liver Failure
Start date
2023-03-01
Primary completion
2025-03-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.